Literature DB >> 15953594

Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes.

Luis Agulló1, David Garcia-Dorado, Noelia Escalona, Marisol Ruiz-Meana, Maribel Mirabet, Javier Inserte, Jordi Soler-Soler.   

Abstract

OBJECTIVE: Although the importance of the cyclic GMP (cGMP) signaling pathway in cardiac myocytes is well established, little is known about its regulation. Ca2+-dependent translocation of nitric oxide (NO) sensitive guanylyl cyclase (GCNO) to the cell membrane has been recently proposed to play a role. The aim of this study was to determine the possible functional relevance of GCNO bound to the cardiomyocyte membrane.
METHODS: Cytosolic and particulate fractions of adult rat cardiomyocytes were isolated and blotted, and their GCNO activity was assayed in parallel experiments.
RESULTS: In untreated cardiomyocytes, approximately 30% of beta1-and alpha1-subunits of GCNO and a similar proportion of GCNO activity were found in the particulate fraction. The dependence of GCNO activity on pH, Ca2+, GTP and NO donor concentrations was similar in particulate and cytosolic fractions. Treatment of cardiomyocytes with the ionophore A23187 caused GCNO to translocate to the sarcolemma, increased GCNO activity in this fraction, and potentiated NO-mediated cGMP synthesis. These effects appeared to be mediated by Ca2+-dependent changes on the phosphorylation status of GCNO, since they were enhanced by the non-selective inhibitor staurosporine and by the selective inhibitor of Ca2+/calmodulin-dependent protein kinase KN-93. The effect of drugs increasing intracellular Ca2+ on cGMP synthesis was clearly correlated with their effects on membrane-associated GCNO activity but not with their effects on cytosol-associated GCNO.
CONCLUSION: These results are the first evidence that 1) GCNO is associated with the cell membrane in cardiomyocytes, 2) the regulation of membrane-associated GCNO differs from that of cytosolic GCNO, and 3) membrane association may have a crucial role in determining the response of cells to NO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953594     DOI: 10.1016/j.cardiores.2005.05.021

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  cGMP signalling: from bench to bedside. Conference on cGMP generators, effectors and therapeutic implications.

Authors:  Robert Feil; Barbara Kemp-Harper
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

Review 2.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

3.  Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Authors:  Saumya Ramanathan; Stacy Mazzalupo; Scott Boitano; William R Montfort
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

4.  Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.

Authors:  L S Hoffmann; P M Schmidt; Y Keim; S Schaefer; H H H W Schmidt; J P Stasch
Journal:  Br J Pharmacol       Date:  2009-05-18       Impact factor: 8.739

Review 5.  NO Better Way to Protect the Heart during Ischemia-Reperfusion: To be in the Right Place at the Right Time.

Authors:  Charlotte Farah; Cyril Reboul
Journal:  Front Pediatr       Date:  2015-02-06       Impact factor: 3.418

6.  Newly Identified NO-Sensor Guanylyl Cyclase/Connexin 43 Association Is Involved in Cardiac Electrical Function.

Authors:  Pierre-Antoine Crassous; Ping Shu; Can Huang; Richard Gordan; Peter Brouckaert; Paul D Lampe; Lai-Hua Xie; Annie Beuve
Journal:  J Am Heart Assoc       Date:  2017-12-21       Impact factor: 5.501

Review 7.  Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.

Authors:  Natasha M Rogers; Franziska Seeger; Elsa D Garcin; David D Roberts; Jeffrey S Isenberg
Journal:  Front Physiol       Date:  2014-04-04       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.